Medical Condition News

RSS

Bradykinesia in Parkinson’s disease: an interview with Dr. Joseph Giuffrida, President of Great Lakes NeuroTechnologies

Currently in the United States, there are over 1.5 million people living with Parkinson's and 50,000 new cases reported each year

30 Aug 2012

IQWiG examines added benefit of belimumab for patients with systemic lupus erythematosus

Belimumab has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). Products (AMNOG).

30 Aug 2012

University of Adelaide researchers to produce better quality pasta with health properties

University of Adelaide researchers are working with colleagues in Italy to produce better quality pasta that also adds greater value to human health.

30 Aug 2012

Headphones can damage coating of nerve cells and lead to temporary deafness

Turning the volume up too high on your headphones can damage the coating of nerve cells, leading to temporary deafness; scientists from the University of Leicester have shown for the first time.

30 Aug 2012

RegeneRx’s Thymosin Beta 4 can promote recovery of diabetic peripheral neuropathy

RegeneRx Biopharmaceuticals, Inc. reports that U.S. researchers have found that Thymosin Beta 4 (Tβ4) promotes statistically significant recovery of peripheral neuropathy in type II diabetic mice including recovery of neurovascular dysfunction in the sciatic nerve and recovery of neurological function.

30 Aug 2012

UH pharmacologist examines age-related oxidative, inflammatory stress

Gaining new insight to managing sodium balance and blood pressure, investigators at the University of Houston (UH) College of Pharmacy believe their work may identify future therapeutic targets to control hypertension.

30 Aug 2012

Southampton Traffic Light test could easily diagnose liver fibrosis and cirrhosis

A new 'traffic light' test devised by Dr Nick Sheron and colleagues at University of Southampton and Southampton General Hospital could be used in primary care to diagnose liver fibrosis and cirrhosis in high risk populations more easily than at present.

30 Aug 2012

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

A study published in the most recent issue of the Journal of the American Medical Association (JAMA) presented encouraging news regarding physicians' ability to determine blood flow and associated coronary artery disease (CAD) using noninvasive CT scanning technology.

30 Aug 2012

Octogenarians have better survival rates following heart valve surgery

Octogenarians need not shy away from heart valve surgery because of their age; however, those sent home following surgery do better than those discharged to care facilities, according to an observational study published in the September 2012 issue of The Annals of Thoracic Surgery.

30 Aug 2012

GWSMHS professor to study correlation between genetics and susceptibility to drug abuse

Norman H. Lee, Ph.D., professor of pharmacology at the George Washington University School of Medicine and Health Sciences (SMHS), received a total of $405,001 in grant funding from the National Institute on Drug Abuse (NIDA) to continue to study the correlation between genetics and susceptibility to drug abuse.

30 Aug 2012

Johns Hopkins team creates synthetic protein that can help locate tumors

Johns Hopkins researchers have created a synthetic protein that, when activated by ultraviolet light, can guide doctors to places within the body where cancer, arthritis and other serious medical disorders can be detected.

30 Aug 2012

CCE, Accretive Health partner to develop novel oncology care management

Accretive Health, Inc., a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.

30 Aug 2012

Combination of POZEN’s PA32540 and clopidogrel results in greater antiplatelet effects

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced the presentation of Phase 1 data, at the European Society of Cardiologists 2012 Congress, from a study of PA32540, a novel coordinated-delivery tablet of enteric-coated (EC) aspirin (325 mg) and immediate-release (IR) omeprazole (40 mg).

30 Aug 2012

Protalex announces results from PRTX-100 Phase 1b trial on active rheumatoid arthritis

Protalex, Inc., a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA), today announced results from its recently completed Phase 1b randomized, multiple-dose, dose-escalation study.

30 Aug 2012

SureGene selects PGXL as laboratory provider for STA2R genetic panel

SureGene has chosen PGXL as laboratory provider for its proprietary STA2R genetic panel, which promises to revolutionize the treatment of schizophrenia.

30 Aug 2012

Nipro Diagnostics, NextGen enter agreement for TRUEresult blood glucose monitoring system

NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with Nipro Diagnostics, Inc. to integrate its TRUEresult blood glucose monitoring system into the NextGen Ambulatory EHR.

30 Aug 2012

Collegium commences enrollment in Oxycodone DETERx Phase 3 study in chronic lower back pain

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain today announced that it has initiated enrollment in its Phase 3 clinical study for Oxycodone DETERx (COL-003).

30 Aug 2012

Heart Rhythm Society, ECAS and EHRA develop 2012 expert consensus statement on AF ablation

The 2012 expert consensus statement on catheter and surgical ablation of atrial fibrillation was developed by the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC), and the European Cardiac Arrhythmia Society (ECAS) and published in their respective journals: Heart Rhythm, EP Europace and the Journal of Interventional Cardiovascular Electrophysiology (JICE).

30 Aug 2012

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed a global license and development agreement with the Danish company Genmab A/S for the anti-cancer compound, daratumumab.

30 Aug 2012

PrecisionMed announces enrollment of first donor into Amyotrophic Lateral Sclerosis Registry

PrecisionMed Inc., the world's leading supplier of human cerebrospinal fluid (CSF), today announced enrollment of the first donor into the PrecisionMed Amyotrophic Lateral Sclerosis (ALS) Registry.

30 Aug 2012

Medical Condition News

Bradykinesia in Parkinson’s disease: an interview with Dr. Joseph Giuffrida, President of Great Lakes NeuroTechnologies

IQWiG examines added benefit of belimumab for patients with systemic lupus erythematosus

University of Adelaide researchers to produce better quality pasta with health properties

Headphones can damage coating of nerve cells and lead to temporary deafness

RegeneRx’s Thymosin Beta 4 can promote recovery of diabetic peripheral neuropathy

UH pharmacologist examines age-related oxidative, inflammatory stress

Southampton Traffic Light test could easily diagnose liver fibrosis and cirrhosis

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

Octogenarians have better survival rates following heart valve surgery

GWSMHS professor to study correlation between genetics and susceptibility to drug abuse

Johns Hopkins team creates synthetic protein that can help locate tumors

CCE, Accretive Health partner to develop novel oncology care management

Combination of POZEN’s PA32540 and clopidogrel results in greater antiplatelet effects

Protalex announces results from PRTX-100 Phase 1b trial on active rheumatoid arthritis

SureGene selects PGXL as laboratory provider for STA2R genetic panel

Nipro Diagnostics, NextGen enter agreement for TRUEresult blood glucose monitoring system

Collegium commences enrollment in Oxycodone DETERx Phase 3 study in chronic lower back pain

Heart Rhythm Society, ECAS and EHRA develop 2012 expert consensus statement on AF ablation

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

PrecisionMed announces enrollment of first donor into Amyotrophic Lateral Sclerosis Registry

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News